Pediatrics
While Cures Within Reach is disease-agnostic and geography-agnostic, some of our funding partners have strategic interests in specific population groups. Therefore, in addition to our disease-specific and geographic repurposing communities, we have a Pediatrics Repurposing Community that utilizes the speed and cost-effectiveness of testing already approved therapies in new indications to improve the quality and length of life of pediatric patients.
Our repurposing research and events within the Pediatrics Repurposing Community all focus on connecting our many stakeholder groups together in our shared goal: driving more treatments to more patients more quickly through repurposing.
Our efforts include finding and funding clinical repurposing projects to quickly impact pediatric patients in any disease area.
Funding Opportunity RFPs for Pediatrics:
- ReGRoW: Funding for Underresourced Researchers in Low and Lower-Middle Income Countries 2025: accepting budgets of up to $65,000 for clinical repurposing trials in any disease led by an underresourced researcher in any LMIC, as defined by the World Bank. SUBMISSIONS DUE MARCH 28, 2025.
- Repurposing Research for Chicago 2025: Pediatrics is one of four Chicago RFP tracks. Accepting budgets of up to $100,000 for clinical repurposing trials from Chicago area research institutions. Specific focus areas for the other tracks include Early Stage Investigators, Health Equity and Veterans/Military issues. DEADLINE EXTENDED: SUBMISSIONS DUE MAY 16, 2025.
- Track 3 – Pediatrics: clinical repurposing trials to address unmet medical needs of pediatric patients, including adding a pediatric arm to an adult clinical repurposing trial.
More information on our Funding Opportunities / RFPs page.
In 2021, we held CureAccelerator Live! for Pediatric Rare Diseases. Click here to watch the full event and highlights video or read about the three funded trials from this unique philanthropic pitch event.
As we develop and grow this Pediatric Community, we thank our early collaborative partner:
Our ongoing pediatric trials:
Pediatrics: Completed Trials and Press Releases
(in the past 5 years)
